Author

Marta Biondi

ORCID 0000-0003-1156-2255Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Alice PievaniiD· 2 shared Andrea BiondiiD· 2 shared Erica GrassenisiD· 2 shared Marta SerafiniiD· 2 shared Sarah TettamantiiD· 2 shared Andrea LiaiD· 1 shared Antonio GaleoneiD· 1 shared Antonio Maria AlvianoiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Alice PievaniORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintJun 23, 2026

A humanized ossicle platform for real-time tracking and preclinical assessment of CAR-based immunotherapies in acute myeloid leukemia

Samantha Donsante, Mara Algeri, Marta Biondi…·Marta Serafini

This paper develops a humanized ossicle model to track CAR-T cell dynamics and AML progression in real-time, enabling preclinical assessment of immunotherapies.

DOI 10.64898/2026.06.22.733693

humanexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintApr 24, 2026

Differential TIM-3 glycosylation enables specific dual targeting CAR-T therapy in acute myeloid leukemia

Marta Biondi, Antonio Galeone, Corinne Arsuffi…·Marta Serafini

This study develops a dual CAR-T therapy targeting CD33 and TIM-3 in AML, showing improved specificity and efficacy through glycosylation-modulated TIM-3 recognition.

DOI 10.64898/2026.04.22.719217

humanproteomics

𝕏 PostBluesky